No abstract available
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antigens, CD20 / metabolism
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
CD5 Antigens / metabolism*
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Follow-Up Studies
-
Heart Neoplasms / drug therapy
-
Heart Neoplasms / metabolism
-
Heart Neoplasms / pathology*
-
Heart Neoplasms / surgery
-
Heart Ventricles
-
Humans
-
Interferon Regulatory Factors / metabolism
-
Leukocyte Common Antigens / metabolism
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / metabolism
-
Lymphoma, Large B-Cell, Diffuse / pathology*
-
Lymphoma, Large B-Cell, Diffuse / surgery
-
Male
-
Middle Aged
-
PAX5 Transcription Factor / metabolism
-
Prednisone / therapeutic use
-
Rituximab
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20
-
CD5 Antigens
-
Interferon Regulatory Factors
-
PAX5 Transcription Factor
-
PAX5 protein, human
-
R-CHOP protocol
-
interferon regulatory factor-4
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Leukocyte Common Antigens
-
Prednisone